Neuro-Ophthalmology News

Rituximab modulated retinal atrophy in relapsing-remitting MS, with attenuating effects that may be more significant after 12 months of treatment, according to results of an observational study published in Neurology.

Black patients with MS or neuromyelitis optica spectrum disorder experienced faster repopulation of B cells 6 to 12 months after rituximab or ocrelizumab infusion compared with white patients, according to preliminary results.

Decreased ganglion cell-inner plexiform layer thickness at baseline as assessed by optical coherence tomography correlated with a four-fold greater risk for long-term disability worsening in MS, according to findings published in Neurology.

The American Heart Association issued a scientific statement with recommendations for the diagnosis, treatment and secondary prevention of central retinal artery occlusion, or CRAO.

Patients with Parkinson’s disease and visual dysfunction had a higher risk for cognitive impairment and greater white matter degeneration compared with those without visual dysfunction, according to results published in Movement Disorders.

Asymptomatic brain lesions were rarely observed on conventional MRI in patients with clinically stable, antibody-seropositive neuromyelitis optica spectrum disorder, according to study results of nearly 300 patients.

The FDA granted orphan drug designation to AMX0035, an investigational neuroprotective therapy, for Wolfram syndrome, a rare neurodegenerative disease that causes severe neurological disabilities and results in premature death.

Patients with idiopathic Parkinson’s disease who had lower retinal thickness at baseline demonstrated an increased risk for cognitive decline after 3 years, suggesting layer thickness could have predictive value.

Clinicians may refer suspicious glaucoma diagnoses to neuro-ophthalmologists, according to a presentation at the virtual Women in Ophthalmology Summer Symposium.

Enspryng lowered relapse severity in patients with neuromyelitis optica spectrum disorder, according to data from the double-masked periods of the SAkura phase 3 studies presented at the MSVirtual2020 meeting.